DSE : BEACONPHAR

Beacon Pharmaceuticals PLC

Pharmaceutical Preparations · Bangladesh

Last price 92.7 BDT (At close: Oct 29, 2026) · Market cap 21.41B

Latest research: Beacon Pharmaceuticals valuation report: fair value BDT 22–88.1 (Oct 2026) · Beacon's profit doubled in FY2026, but 16% long-run returns support a fair value range of BDT 22–88 (base 52)

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Beacon Pharmaceuticals PLC engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech, and genetic engineering products in Bangladesh and internationally. The company offers general, oncology, biotech, and chronic care products. It also provides products in various therapeutic categories such as oncology, hematology, anti-cancer, hepatology, nephrology, antibiotics, analgesics, anti-diabetics, respiratory, cardiovascular, dermatology, gastrointestin...

Technical report: trend, RSI, support and resistance, charts

Reports